Suxamethonium Chloride

Products Suxamethonium chloride is commercially available as a solution for injection (lysthenone, succinoline). It was introduced in the 1950s and has been approved in many countries since 1954. Suxamethonium chloride is also known as succinylcholine or succinylcholine chloride, especially in English. In jargon, it is also called Suxi or Sux. Structure and properties Suxamethonium chloride … Suxamethonium Chloride

Carisoprodol

Products In many countries, there are no drugs containing carisoprodol on the market. In other countries, it is available in tablet form (Soma, Somadril). It has been approved in the United States since 1959. In 2007, the European Medicines Agency concluded that the benefits of the drug did not outweigh the risks. Structure and properties … Carisoprodol

Cyclobenzaprine

Products Cyclobenzaprine is commercially available in the United States and elsewhere in the form of film-coated tablets. No finished drug products containing cyclobenzaprine are currently registered in many countries. Structure and properties Cyclobenzaprine (C20H21N, Mr = 275.4 g/mol) is present in drugs as cyclobenzaprine hydrochloride, a white crystalline powder that is soluble in water. It … Cyclobenzaprine

Methocarbamol

Products Methocarbamol is approved in tablet form (Metoflex). However, it is an older active ingredient, as it was first approved in the United States, for example, in the 1950s. Structure and properties Methocarbamol (C11H15NO5, Mr = 241.2 g/mol) is a carbamate derivative. It exists as a white powder and is sparingly soluble in water. Methocarbamol … Methocarbamol

Dantrolene

Products Dantrolene is commercially available in capsule form and as a solution for injection (dantamacrine, dantrolene). It has been approved in many countries since 1983. It was developed in the 1960s and 70s. This article refers primarily to peroral therapy. Structure and properties Dantrolene (C14H10N4O5, Mr = 314.3 g/mol) is present in the drug as … Dantrolene

Tizanidin

Products Tizanidine is commercially available in tablet and sustained-release capsule form (Sirdalud, Sirdalud MR, generics). It has been approved in many countries since 1983. Structure and properties Tizanidine (C9H8ClN5S, Mr = 253.7 g/mol) is present in drugs as tizanidine hydrochloride, a white crystalline powder that is somewhat soluble in water. It is an imidazoline and … Tizanidin

Botulinum Toxin

Products Botulinum toxin is commercially available as an injectable. It has been approved in many countries since 1994. The drugs contain a dried preparation reconstituted with sterile physiological saline (sodium chloride 0.9%). Structure and properties Botulinum toxin type A is the toxin of the anaerobic and gram-positive bacterium . Various products are commercially available, which … Botulinum Toxin

Baclofen

Products Baclofen is commercially available as in tablet form and as a solution for injection (Lioresal, generics). It has been approved in many countries since 1970. Structure and properties Baclofen (C 10 H 12 ClNO 2 , M r = 213.7 g/mol) exists as a white and odorless powder that is sparingly soluble in water. … Baclofen

Idrocilamide

Products Idrocilamide is commercially available as a cream (Talval). It has been approved in many countries since 1985. Idrocilamide was also available in tablet form in France under the brand name Brolitene, but these are out of commerce. Structure and properties Idrocilamide (C11H13NO2, Mr = 191.23 g/mol) Effects Idrocilamide (ATC MO2AX10) has muscle relaxant, anti-inflammatory, … Idrocilamide

Tolperisone

Products Tolperisone is commercially available in the form of film-coated tablets (Mydocalm, generic). It has been approved in many countries since 1966. Structure and properties Tolperisone (C16H23NO, Mr = 245.36 g/mol) is chiral and is present in drugs as racemate and tolperisone hydrochloride. It is a piperidine derivative and a propiophenone. Tolperisone has structural similarities … Tolperisone

Rocuronium Bromide

Products Rocuronium bromide is commercially available as a solution for injection (esmeron, generic). It was approved in the United States in 1994 and in many countries in 1995. Structure and properties Rocuronium bromide (C32H53BrN2O4, Mr = 609.7 g/mol) exists as a nearly white to pale yellow, slightly hygroscopic powder that is readily soluble in water. … Rocuronium Bromide